The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
03 Aug, 2026, 12.43 AM IST
ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
30 Jul, 2026, 05.16 PM IST
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
27 Jul, 2026, 12.52 PM IST
Bain Capital in advanced talks for 25% stake in IndusInd Insurance, marking its first India insurance betBain Capital is nearing a deal to buy a significant stake in IndusInd General Insurance. This acquisition could value the insurer at over s...
27 Jul, 2026, 05.30 AM IST
Bain Capital acquires Vitabiotics: UK nutraceutical giant with India’s Meyer Organics valued at $850-900 millionPrivate equity firm Bain Capital has agreed to acquire UK-based nutraceutical company Vitabiotics, expanding its presence in the global wel...
25 Jul, 2026, 06.00 AM IST
Bain Capital to accquire UK's leading vitamin company VitabioticsPrivate equity firm Bain Capital will acquire UK nutraceutical company Vitabiotics, including its India business Meyer Organics and African...
24 Jul, 2026, 01.41 PM IST
Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
21 Jul, 2026, 02.58 PM IST
LetterOne taps Rahul Mukim to spearhead $2 billion India pushLuxembourg-based LetterOne appointed Rahul Mukim to lead its India investments. The firm plans a significant $2 billion investment program ...
17 Jul, 2026, 04.57 PM IST
FSSAI crackdown serves food for thought as packaged food makers seek clearer rulesIn a bid to strengthen consumer protection, India's food regulatory body is intensifying efforts against packaged food companies. The lack ...
15 Jul, 2026, 12.16 AM IST
Ethanol ecosystem: Judging fear by noise is not evidence; 15 stocks from the ecosystemSugar is one of the oldest distressed sectors in India. For decades it has swung between glut and shortage, carried heavy debt, was depende...
13 Jul, 2026, 01.53 PM IST
Government starts industry consultations on next phase of food processing PLIThe government is planning an expanded Production-Linked Incentive Scheme for the food processing sector. Consultations were held with indu...
08 Jul, 2026, 07.36 PM IST
Raising the bar: Saying it with chocolates, from pastries to perfumeChocolate is a versatile ingredient celebrated for its intricate taste and diverse forms. It's integrated into an array of products, from b...
07 Jul, 2026, 03.58 PM IST
India's wellness industry poised for growth amid focus on preventive healthcare, rising income: EBG Group chiefIndia's wellness market, valued at over $150 billion, is set for growth fueled by rising health consciousness and disposable incomes. EBG G...
06 Jul, 2026, 06.07 PM IST
India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boomIndia's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. Th...
28 Jun, 2026, 06.00 PM IST
India's growth story, not AI trade reversal, will drive foreign flows: Sameer DalalIndia's economic strength, not AI's decline, will drive foreign capital inflows, according to Sameer Dalal. He believes AI's market correct...
24 Jun, 2026, 11.59 AM IST
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
23 Jun, 2026, 08.03 PM IST
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
23 Jun, 2026, 12.05 PM IST